Roche Holding AG ROG-CH:Swiss Exchange

*Data is delayed | CHF
Last | 1:45 PM CEST
303.10quote price arrow up+3.55 (+1.19%)
Volume
350,970
52 week range
290.55 - 356.50

...

Loading . . .
  • Open299.95
  • Day High303.20
  • Day Low299.35
  • Prev Close299.55
  • 52 Week High356.50
  • 52 Week High Date05/18/20
  • 52 Week Low290.55
  • 52 Week Low Date10/30/20

Key Stats

  • Market Cap280,139.2M
  • Shares Out853.13M
  • 10 Day Average Volume1.12M
  • Dividend9.10
  • Dividend Yield3.00%
  • Beta0.08
  • YTD % Change-1.91

KEY STATS

  • Open299.95
  • Day High303.20
  • Day Low299.35
  • Prev Close299.55
  • 52 Week High356.50
  • 52 Week High Date05/18/20
  • 52 Week Low290.55
  • 52 Week Low Date10/30/20
  • Market Cap280,139.2M
  • Shares Out853.13M
  • 10 Day Average Volume1.12M
  • Dividend9.10
  • Dividend Yield3.00%
  • Beta0.08
  • YTD % Change-1.91

RATIOS/PROFITABILITY

  • EPS (TTM)16.52
  • P/E (TTM)18.35
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO3:0303:03
We're really excited that these genomics companies, says Ark's Simon Barnett

Profile

MORE
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including...
Christoph Franz Ph.D.
Non-Executive Chairman
Alan Hippe
Chief Financial Officer
Claudia Boeckstiegel
General Counsel
Address
Grenzacherstr. 124
Basel
4058
Switzerland